Manufacturer record
Aishwarya Healthcare: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Aishwarya Healthcare (Himachal Pradesh) were declared Not of Standard Quality between July 2020 and March 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Aishwarya Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bupivacaine Hydrochloride In Dextrose Injection USP | AA4009Mfg 2024-03 · Exp 2026-02 | Particulate matter (visible) and DescriptionDescription | CDL, KolkataCDSCO lab | Mar 2025 |
| Hepacel 25000 IU/5 ml (Heparin Sodium Injection I.P.) | ATFT2002Mfg 2022-08 · Exp 2024-07 | AssayAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Bunase 0.5 Respules (Budesonide Nebuliser Suspension BP) | RS1195Mfg 2021-11 · Exp 2023-10 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Mar 2022 |
| LORAZEPAM INJECTION IP | RS1071Mfg 2021-06 · Exp 2023-05 | AssayAssay | RDTL ChandigarhState lab | Sep 2021 |
| Budesonide Nebuliser Suspension BP (BUPICORT 0.5 MG/2 ML) | RS0059Mfg 2020-03 · Exp 2022-02 | AssayAssay | RDTL ChandigarhState lab | Sep 2021 |
| (FLUCONAZOLE INJECTION USP 0.2% W/V) | A9123Mfg 2019-04 · Exp 2021-03 | Organic ImpuritiesOther | RDTL ChandigarhCDSCO lab | Jul 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.